Effect of Arka Taila and Its Cream In Vicharchika

Pharmaceutico Analytical and Clinical Evaluation of Arka Taila and Its Cream In The Management of Vicharchika

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/08/027269

Enrollment

Registered

2020-08-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: Arka taila and Arogyavardhini Vati: Arka taila for external application as per the requirement two times a day along with internal administration of Arogyavardhini Vati 250mg TDS Interv

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having clinical signs and symptoms of Vicharchika like Kandu, srava, shyava varna. 2.Patients between the age group of (18-70) years of age. 3.Patients of Dry Eczema

Exclusion criteria

Exclusion criteria: 1.Patients suffering from chronic skin diseases. 2.Patients of Vicharchika having secondary infection 3.Patients under long term Steroids and cytotoxic treatments. 4.Patients with concomitant illness like HTN, DM. 5.Patients with evidence of malignancy.

Design outcomes

Primary

Measure	Time frame
To compare Clinical efficacy of arka tail and its cream in vicharchikaTimepoint: 28 day	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Bhupender Kumar

National Institute of Ayurveda

headrasa@gmail.com9887181781

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026